Arkolith/Insider Trading/NBRV/Form 4

Schroeder Theodore R

Chief Executive Officer, DirectorNabriva Therapeutics plc (NBRV) · full profile →Form 4 · filed Feb 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2022Tax withholding(F)125$0.48$60315K
Jan 29, 2022Tax withholding(F)11K$0.45$5K315K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-010535) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML